FindTrial
Sign In

A medical records based study for sedation and Analgesia Usage in critically ill patients with novel coronavirus pneumonia (COVID-19)

Sedation and Analgesia Usage in critically ill patients with novel coronavirus pneumonia (COVID-19)

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000030758
Enrollment
Unknown
Registered
2020-03-13
Start date
2020-03-10
Completion date
Unknown
Last updated
2020-03-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Novel coronavirus pneumonia (COVID-19)

Interventions

NIV group:no
MV group:no

Sponsors

Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
Lead Sponsor

Eligibility

Sex/Gender
All
Age
14 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1) The diagnosis meets the diagnostic criteria for new coronavirus pneumonia; 2) Patients receiving NIV or MV treatment.

Exclusion criteria

Exclusion criteria: 1) Age < 14 years; 2) Pregnant women; 3) Incomplete information of necessary clinical data.

Design outcomes

Primary

MeasureTime frame
Dose of analgesic and sedative drugs;28-day mortality rate;—

Countries

China

Contacts

Public ContactZhigang He

Eergency / Intensive Care Department of Tongji Hospital

1097685807@qq.com+86 18827001384

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026